Breaking News Instant updates and real-time market news.

VRX

Valeant

$17.16

-0.28 (-1.61%)

17:49
11/29/16
11/29
17:49
11/29/16
17:49

Valeant CEO: GI franchise remains 'core asset for future growth potential'

As part of the company's announcement Tuesday of a sales force expansion targeting its gastrointestinal products Xifaxan and Relistor, Valeant CEO Joe Papa commented: "Our goal in building a primary care sales force is to maximize opportunities for Xifaxan and Relistor to help our products reach full potential. Xifaxan and Relistor are integral to our gastrointestinal franchise which remains a core asset for future growth potential in the hands of Valeant." Xifaxan and Relistor are developed under Valeant's Salix unit. The company announced in early November that it is "currently in discussions with third parties for various divestitures including but not limited to Salix," with Wells Fargo analyst David Maris commenting at the time that a Salix sale could "significantly" reduce the company's growth profile. PRICE ACTION: Shares of Valeant are now flat in post-market trading after initially trading down 0.5%.

  • 13

    Dec

  • 14

    Dec

  • 16

    Feb

VRX Valeant
$17.16

-0.28 (-1.61%)

11/18/16
DBAB
11/18/16
NO CHANGE
Target $24
DBAB
Hold
Deutsche still likes near-term setup for Valeant shares
Deutsche Bank analyst Gregg Gilbert said yesterday that he still likes the near-term setup for shares of Valeant Pharmaceuticals after federal prosecutors announced criminal charges against former executive Gary Tanner and the former CEO of Philidor. It is "good to see" that Valeant and other senior executives were not charged, Gilbert told investors in a research note. The charges could be an important step forward as the company and new management team distance themselves from the past, Gilbert wrote. The analyst points out that the bar for 2016 has already been lowered and that new CFO Paul Herendeen thinks of guidance as a commitment. Gilbert keeps a Hold rating on Valeant with a $24 price target. The stock closed yesterday up 12c to $17.98.
11/18/16
ADAM
11/18/16
NO CHANGE
Target $17
ADAM
Hold
Valeant negative headlines remain a risk, says Canaccord
Canaccord analyst Neil Maruoka noted yesterday's headlines regarding criminal charges against a former Valeant executive. He said although the charges are not pertinent to Valeant it underscores the negative headline risk that is associated with owning the shares. Maruoka said the company's lower guidance suggests growth headwinds into next year and believes the company still needs to sell assets to de-lever. Maruoka maintained his Hold rating and $17 price target on Valeant shares.
11/23/16
MZHO
11/23/16
DOWNGRADE
Target $11
MZHO
Underperform
Valeant downgraded to Underperform from Neutral at Mizuho
Mizuho analyst Irina Koffler downgraded Valeant Pharmaceuticals to Underperform, her firm's sell rating equivalent, and cut her price target for the shares to $11 from $25. The drugmaker closed yesterday at $17.83. Koffler believes growth challenges, 2017 guidance risk, legal overhangs and weaker asset divestitures create an unfavorable risk/reward profile. She expects the shares to trend lower over the next 6-12 months.
11/29/16
DBAB
11/29/16
NO CHANGE
Target $24
DBAB
Hold
Deutsche weighs impact on Valeant should Salix be sold
Deutsche Bank analyst Gregg Gilbert hopes to hear closure soon on a potential sale of Salix by Valeant Pharmaceuticals. While a sale is not a "no-brainer" given the unit's growth and durability, a deal could improve Valeant's debt situation and add to its value, Gilbert tells investors in a research note. His preliminary analysis suggests that a sale of Salix for $10B coupled with de-levering would be "significantly" dilutive to earnings but accretive to Valeant's value. His analysis yields earnings dilution of 26%-27% in 2018- 2021 and an increase in the company's theoretical discounted cash flow value to $32 from $24. Gilbert continues to like the near-term setup in shares of Valeant but keeps a Hold rating on the shares with a $24 price target. The pharmaceutical closed yesterday up 44c to $17.44.

TODAY'S FREE FLY STORIES

BA

Boeing

$176.59

1.2274 (0.70%)

11:05
02/23/17
02/23
11:05
02/23/17
11:05
Hot Stocks
Boeing reports 31 new orders in weekly update »

Boeing, on its website,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
52-Week Bill Announcement CUSIP Number data reported »

52-Week Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
52-Week Bill Announcement Offering Amount data reported »

52-Week Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
6-Month Bill Announcement CUSIP Number data reported »

6-Month Bill Announcement…

11:05
02/23/17
02/23
11:05
02/23/17
11:05
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

FRTA

Forterra

$18.52

-0.14 (-0.75%)

11:04
02/23/17
02/23
11:04
02/23/17
11:04
Conference/Events
Forterra management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 30

    Mar

LMT

Lockheed Martin

$263.90

-2.025 (-0.76%)

11:03
02/23/17
02/23
11:03
02/23/17
11:03
Hot Stocks
Trump says Lockheed Martin cut plane costs by $700M »

President Trump, during a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

LHCG

LHC Group

$49.26

0.36 (0.74%)

11:02
02/23/17
02/23
11:02
02/23/17
11:02
Conference/Events
LHC Group management to meet with Oppenheimer »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 09

    Mar

  • 21

    Mar

NTT

Nippon Telegraph

$42.17

0.22 (0.52%)

11:02
02/23/17
02/23
11:02
02/23/17
11:02
Hot Stocks
NTT Communication to acquire 100% ownership of RagingWire Data Centers »

RagingWire Data Centers,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLSE

Pulse Biosciences

$14.49

0.66 (4.77%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Periodicals
Pulse Biosciences mentioned cautiously by TheStreetSweeper 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:01
02/23/17
02/23
11:01
02/23/17
11:01
General news
Kansas City Fed Manufacturing Index Level data reported »

February Kansas City Fed…

NLSN

Nielsen

$45.10

0.215 (0.48%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Hot Stocks
Nielsen says Univision signs multiyear agreement with Nielsen Audio »

Nielsen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 06

    Mar

FEYE

FireEye

$11.23

-0.57 (-4.83%)

11:01
02/23/17
02/23
11:01
02/23/17
11:01
Options
Call buyers jump as FireEye shares catch fire »

Call buyers jump as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

11:00
02/23/17
02/23
11:00
02/23/17
11:00
General news
EIA crude inventories for week of February 17 »

Crude oil inventories…

11:00
02/23/17
02/23
11:00
02/23/17
11:00
General news
Treasury 7-year auction outlook: »

Treasury 7-year auction…

10:55
02/23/17
02/23
10:55
02/23/17
10:55
General news
U.S. tax refunds »

U.S. tax refunds are…

ORCL

Oracle

$42.84

0.33 (0.78%)

10:51
02/23/17
02/23
10:51
02/23/17
10:51
Options
Large option block opened in Oracle as shares reach 52-week highs »

Large option block opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:50
02/23/17
02/23
10:50
02/23/17
10:50
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

, INTC

Intel

$36.07

-0.45 (-1.23%)

10:50
02/23/17
02/23
10:50
02/23/17
10:50
Hot Stocks
Analysts say sell NVIDIA amid competitive changes, gaming slowdown »

Shares of NVIDIA (NVDA)…

NVDA

NVIDIA

$110.76

-0.31 (-0.28%)

INTC

Intel

$36.07

-0.45 (-1.23%)

AMD

AMD

$14.28

0.28 (2.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 27

    Feb

  • 05

    Mar

  • 16

    Mar

  • 19

    Mar

  • 04

    Apr

  • 05

    Apr

AMCX

AMC Networks

$57.50

-0.19 (-0.33%)

10:46
02/23/17
02/23
10:46
02/23/17
10:46
Hot Stocks
AMC Networks sees Q1 as most challenging time for AOI comps »

On the call, the company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

FCX

Freeport McMoRan

$13.77

0.0354 (0.26%)

10:46
02/23/17
02/23
10:46
02/23/17
10:46
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

HD

Home Depot

$145.90

0.65 (0.45%)

, LOW

Lowe's

$76.75

-0.055 (-0.07%)

10:45
02/23/17
02/23
10:45
02/23/17
10:45
Hot Stocks
Analyst says buy Home Depot as market underestimates housing recovery »

Morgan Stanley upgraded…

HD

Home Depot

$145.90

0.65 (0.45%)

LOW

Lowe's

$76.75

-0.055 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

  • 15

    Mar

  • 19

    Mar

10:44
02/23/17
02/23
10:44
02/23/17
10:44
Hot Stocks
Breaking Hot Stocks news story  »

Reading International…

AMCX

AMC Networks

$57.50

-0.19 (-0.33%)

10:42
02/23/17
02/23
10:42
02/23/17
10:42
Hot Stocks
AMC Networks sees continued growth in international cable networks »

The company noted that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

ARNC

Arconic

$30.50

-0.05 (-0.16%)

10:42
02/23/17
02/23
10:42
02/23/17
10:42
Hot Stocks
Elliott reiterates recommendation Arconic board consider Lawson as next CEO »

Elliott Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.